NFKB1 and cancer: Further experiments in cancer as well as immortalized noncancerous cell lines showed that knockdown of UBXN1 potentiates TNFα-triggered NF-κB signaling, suggesting UBXN1 is a physiological suppressor of the NF-κB pathway [123].